Please log in to access this page.

Lac-hydrin and Augmentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lac-hydrin (ammonium lactate) and Augmentin (amoxicillin; clavulanate potassium). Common drug interactions include atelectasis among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Lac-hydrin and Augmentin. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Lac-hydrin?

Lac-hydrin has active ingredients of ammonium lactate. eHealthMe is studying from 534 Lac-hydrin users. Check the latest studies of Lac-hydrin.

What is Augmentin?

Augmentin has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 42,620 Augmentin users. Check the latest studies of Augmentin.



On Jul, 20, 2026

22 people who take Lac-hydrin and Augmentin together, and have interactions are studied.

Lac-hydrin and Augmentin drug interactions.

What are the common drug interactions of Lac-Hydrin and Augmentin, by gender? *:

female:

  1. Atelectasis (partial or complete collapse of the lung)
  2. Back pain
  3. Benign ovarian tumour
  4. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  5. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  6. Chest pain
  7. Cholesteatoma (abnormal skin growth in the middle ear behind the eardrum)
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Deafness neurosensory
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

male:

  1. Anxiety
  2. Asthenia (weakness)
  3. Actinic keratosis (skin disease due to sun exposure)
  4. Activities of daily living impaired
  5. Adnexa uteri mass (ovarian cysts)
  6. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  7. Anaemia (lack of blood)
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Arteriosclerosis (thickening and hardening of arteries)
  10. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)

What are the common drug interactions of Lac-Hydrin and Augmentin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Confusional state
  2. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  3. Dyspnoea (difficult or laboured respiration)
  4. Haemorrhage subcutaneous (bleeding from skin)
  5. Mood disorder (a condition characterized by distorted, excessive or inappropriate moods or emotions)
  6. Purpura (purplish discoloration of the skin)
  7. Pyrexia (fever)
  8. Rash pruritic (redness with itching)
  9. Rigors (an episode of shaking or exaggerated shivering)
  10. Sedation

50-59:

  1. Actinic keratosis (skin disease due to sun exposure)
  2. Back pain
  3. Benign ovarian tumour
  4. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  5. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  6. Chest pain
  7. Cholesteatoma (abnormal skin growth in the middle ear behind the eardrum)
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Deafness neurosensory
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

60+:

  1. Hypogeusia (reduced ability to taste things (to taste sweet, sour, bitter, or salty substances))

What are the existing conditions these people have? *

  1. Metastases To Bone (cancer spreads to bone): 14 people, 63.64%
  2. Multiple Myeloma (cancer of the plasma cells): 2 people, 9.09%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.09%
  4. Breast Cancer Metastatic: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Lac-hydrin and Augmentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lac-hydrin and Augmentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lac-hydrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Augmentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lac-hydrin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Augmentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ammonium lactate and amoxicillin; clavulanate potassium (the active ingredients of Lac-hydrin and Augmentin, respectively), and Lac-hydrin and Augmentin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: